Pharma channel feed

Ab­b­Vie opts out of in­dus­try trade groups PhRMA, BIO plus Busi­ness Round­table

3 years ago

Up­dat­ed: FDA punts PDU­FA date for an­oth­er in­di­ca­tion for As­traZeneca, Mer­ck­'s can­cer drug Lyn­parza

3 years ago
FDA+

Mer­ck marks 1M Minecraft down­loads in gam­ing-meets-sci­ence ed­u­ca­tion ef­fort

3 years ago
Marketing

US set to pay near­ly $2B for Pfiz­er's Covid-19 treat­ment Paxlovid in 2023

3 years ago

Catal­ent to build a $40M an­a­lyt­i­cal ser­vices fa­cil­i­ty in North Car­oli­na's Re­search Tri­an­gle

3 years ago
Manufacturing

Align­ing drug prices with ICER es­ti­mates could save tens of bil­lions of dol­lars — JA­MA pa­per

3 years ago

Van­da los­es Het­lioz patent court de­ci­sion, vows to ap­peal and ask for stay on Te­va, Apo­tex com­peti­tors

3 years ago
Law

No­var­tis of­floads five eye drugs in deal worth up to $175M

3 years ago
Deals

And then there were 8: Fre­se­nius nabs the lat­est Hu­mi­ra biosim­i­lar ap­proval

3 years ago
FDA+

Af­ter #ASH22: Post-mortem analy­sis on biggest Twit­ter buzz around drugs, stud­ies and bio­phar­mas

3 years ago
Marketing

Eli Lil­ly an­tic­i­pates rev­enue boost in 2023 as it pre­pares to launch slate of new drugs

3 years ago
Financing

In­done­si­a's state-owned phar­ma com­pa­ny strikes deal to man­u­fac­ture Mer­ck’s HPV vac­cine

3 years ago
Manufacturing

No­vo Nordisk ad­dress­es off-la­bel Ozem­pic use as it grap­ples with mul­ti­ple short­ages

3 years ago

Roche wins ear­li­er-than-ex­pect­ed ap­proval for block­buster Tecen­triq in rare soft tis­sue can­cer

3 years ago
FDA+

Mar­ket­ingRx roundup: Pfiz­er teams with NFL play­er for sick­le cell aware­ness; Astel­las crowd­sources pa­tient so­lu­tions

3 years ago
Marketing

#ASH22: No­var­tis PNH drug tops As­traZeneca with what's de­scribed as 'prac­tice-chang­ing' po­ten­tial

3 years ago
R&D

Ab­bott heads up new ad­vo­ca­cy ef­fort for con­cus­sion aware­ness with spokesper­son, ac­tress Rebel Wil­son

3 years ago
Marketing

Up­dat­ed: FDA ap­proves Mi­rati's KRAS drug in non-small cell lung can­cer

3 years ago
R&D
FDA+

#ASH22: Re­gen­eron claims it has set a 'new bench­mark' in fol­lic­u­lar lym­phoma

3 years ago
R&D

Seagen rolls out da­ta for Ad­cetris com­bi­na­tion to treat Hodgkin lym­phoma

3 years ago

Sanofi teams up sci­ence and sports for Paris 2024 Olympics spon­sor­ship, ex­tend­ing its #WeN­ev­er­Set­tle ethos

3 years ago
Marketing

Clin­i­cal tri­al brand­ing? Biotechs and phar­mas mi­grate name and iden­ti­ty strate­gies even ear­li­er

3 years ago
Marketing

Bill An­der­son to step down as Roche phar­ma chief by mon­th's end

3 years ago
People

Up­dat­ed: Hori­zon's $28B sale to Am­gen was kicked off by Sanofi's in­ter­est

3 years ago
Deals
First page Previous page 154155156157158159160 Next page Last page
A service from the Financial Times